Literature DB >> 3479997

Multiple molecular abnormalities in Ph1 chromosome positive acute lymphoblastic leukaemia.

O Dreazen1, I Klisak, G Jones, W G Ho, R S Sparkes, R P Gale.   

Abstract

The Ph1 chromosome is present in 95% of patients with chronic myelogenous leukaemia (CML). The Ph1 chromosome also occurs in 5-25% of children and adults with acute lymphoblastic leukaemia (ALL). This observation raises questions as to whether these diseases are similar or identical. In patients with CML the c-abl and bcr genes are translocated and abnormally expressed. We studied molecular events related to bcr and c-abl in five patients with ALL to determine its relationship to CML. Four had the Ph1 chromosome; the fifth a probable Ph1 chromosome. c-abl and bcr abnormalities identical to CML were detected in four suggesting a common molecular basis. One patient with the Ph1 chromosome and c-abl translocation lacked these molecular changes but had abnormal c-abl gene transcription apparently unrelated to bcr. These data suggest that Ph1 chromosome positive ALL is heterogeneous; in some patients the molecular abnormality is identical to CML; in others c-abl is likewise involved but via a different mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479997     DOI: 10.1111/j.1365-2141.1987.tb02353.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Structure-guided design of a potent peptide inhibitor targeting the interaction between CRK and ABL kinase.

Authors:  Qingliang Shen; Veer S Bhatt; Inna Krieger; James C Sacchettini; Jae-Hyun Cho
Journal:  Medchemcomm       Date:  2018-02-01       Impact factor: 3.597

2.  Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment.

Authors:  Brittany C Parker; Wei Zhang
Journal:  Chin J Cancer       Date:  2013-11

3.  Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.

Authors:  Anna Schuh; Helene Dreau; Samantha J L Knight; Kate Ridout; Tuba Mizani; Dimitris Vavoulis; Richard Colling; Pavlos Antoniou; Erika M Kvikstad; Melissa M Pentony; Angela Hamblin; Andrew Protheroe; Marina Parton; Ketan A Shah; Zsolt Orosz; Nick Athanasou; Bass Hassan; Adrienne M Flanagan; Ahmed Ahmed; Stuart Winter; Adrian Harris; Ian Tomlinson; Niko Popitsch; David Church; Jenny C Taylor
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02

4.  Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts.

Authors:  Neetha Nanoth Vellichirammal; Abrar Albahrani; Jasjit K Banwait; Nitish K Mishra; You Li; Shrabasti Roychoudhury; Mathew J Kling; Sameer Mirza; Kishor K Bhakat; Vimla Band; Shantaram S Joshi; Chittibabu Guda
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-29       Impact factor: 8.886

Review 5.  Translational genomics in cancer research: converting profiles into personalized cancer medicine.

Authors:  Lalit Patel; Brittany Parker; Da Yang; Wei Zhang
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

6.  Functional annotation of proteome encoded by human chromosome 22.

Authors:  Sneha M Pinto; Srikanth S Manda; Min-Sik Kim; KyOnese Taylor; Lakshmi Dhevi Nagarajha Selvan; Lavanya Balakrishnan; Tejaswini Subbannayya; Fangfei Yan; T S Keshava Prasad; Harsha Gowda; Charles Lee; William S Hancock; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2014-04-29       Impact factor: 4.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.